BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 17482245)

  • 1. Management and outcome of healthy women with a persistently elevated beta-hCG.
    Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
    Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia.
    Boafo-Yirenki M; Everard J; Tidy J; Hancock BW
    J Reprod Med; 2009 May; 54(5):288-90. PubMed ID: 19517692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Letter in response to "The management and outcome of healthy women with a persistently elevated beta-hCG" by Palmieri et al.
    Kohorn E
    Gynecol Oncol; 2008 Mar; 108(3):659; author reply 659-60. PubMed ID: 18177926
    [No Abstract]   [Full Text] [Related]  

  • 8. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of hysteroscopy and laparoscopy in differential diagnosis of gestational trophoblastic neoplasia].
    Feng FZ; Xiang Y; He HJ; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):464-7. PubMed ID: 17961336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia].
    Zhou Y; Feng FZ; Xiang Y; Wan XR
    Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical parameters predicting therapeutic response to surgical management in patients with chemotherapy-resistant gestational trophoblastic neoplasia.
    Feng F; Xiang Y; Li L; Wan X; Yang X
    Gynecol Oncol; 2009 Jun; 113(3):312-5. PubMed ID: 19345988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
    Kohorn EI; Kacinski BM; Stanley ER
    Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unusual cause of elevated serum total beta hCG.
    Buckner CL; Wilson L; Papadea CN
    Ann Clin Lab Sci; 2007; 37(2):186-91. PubMed ID: 17522377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hCG assay in the treatment of trophoblastic disease.
    Pattillo RA; Hussa RO
    J Reprod Med; 1984 Nov; 29(11):802-12. PubMed ID: 6097684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcome of gestational trophoblastic neoplasia patients with residual lung tumor after completion of treatment].
    Yang JJ; Xiang Y; Wan XR; Li JG; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):26-8. PubMed ID: 17331417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.